Lucas P Damiani
Overview
Explore the profile of Lucas P Damiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
2086
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa I, Furtado R, Drager L, de Barros E Silva P, Melo M, Araruna P, et al.
Am Heart J
. 2025 Feb;
285:1-11.
PMID: 39988204
Background: Patients with cancer undergoing chemotherapy with an anthracycline-based regimen are at increased risk of cardiotoxicity, predisposing to heart failure, arrhythmias and death. Whether carvedilol may confer benefit to prevent...
2.
Almeida T, Freitas F, Figueiredo R, Houly S, Azevedo L, Cavalcanti A, et al.
Crit Care Med
. 2025 Feb;
53(2):e269-e281.
PMID: 39982179
Objectives: Platelets play a critical role in the inflammatory response and coagulation. We aimed to evaluate whether the use of acetylsalicylic acid (ASA) would reduce the intensity of organ dysfunction...
3.
Lima I, Nunes J, de Oliveira I, Ferreira S, Munhoz R, Chizzola P, et al.
Sci Rep
. 2024 Dec;
14(1):30167.
PMID: 39627200
Observational studies suggest a U-shaped association between serum potassium (K⁺) levels and mortality in patients with chronic heart failure (CHF). However, the mode of death in patients with HF and...
4.
Zampieri F, Westphal G, Santos M, Gomes S, Gomes J, Negrelli K, et al.
J Crit Care
. 2024 Aug;
84:154892.
PMID: 39096659
Purpose: To assess the effect of antisense therapy to block kallikrein-kinin pathway in COVID-19 patients. Material And Methods: Randomized, placebo-controlled, double blind, controlled trial enrolling hospitalized COVID-19 patients that required...
5.
Tavares C, Azevedo L, Rea-Neto A, Campos N, Amendola C, Kozesinski-Nakatani A, et al.
JAMA
. 2024 Jun;
332(5):401-411.
PMID: 38873723
Importance: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors improve outcomes in patients with type 2 diabetes, heart failure, and chronic kidney disease, but their effect on outcomes of critically ill patients with...
6.
Schiavon C, Cavalcanti A, Oliveira J, Machado R, Santucci E, Santos R, et al.
J Am Coll Cardiol
. 2024 Feb;
83(6):637-648.
PMID: 38325988
Background: Obesity represents a major obstacle for controlling hypertension, the leading risk factor for cardiovascular mortality. Objectives: The purpose of this study was to determine the long-term effects of bariatric...
7.
Furtado R, Barros E Silva P, Fonseca H, Serpa-Neto A, Correa T, Guimaraes H, et al.
Am J Cardiol
. 2023 Dec;
214:18-24.
PMID: 38104755
The cardiovascular safety from azithromycin in the treatment of several infectious diseases has been challenged. In this prespecified pooled analysis of 2 multicenter randomized clinical trials, we aimed to assess...
8.
Zampieri F, Machado F, Veiga V, Azevedo L, Bagshaw S, Damiani L, et al.
Intensive Care Med
. 2023 Dec;
50(1):157.
PMID: 38085337
No abstract available.
9.
Maia I, Kawano-Dourado L, Zampieri F, Damiani L, Nakagawa R, Gurgel R, et al.
Crit Care Resusc
. 2023 Dec;
24(1):61-70.
PMID: 38046839
The best way to offer non-invasive respiratory support across several aetiologies of acute respiratory failure (ARF) is presently unclear. Both high flow nasal catheter (HFNC) therapy and non-invasive positive pressure...
10.
Zampieri F, Cavalcanti A, Di Tanna G, Damiani L, Hammond N, Machado F, et al.
Crit Care Resusc
. 2023 Dec;
24(2):128-136.
PMID: 38045602
It remains unclear whether balanced solutions improve patient-centred outcomes in critically ill patients overall and whether the treatment effect is heterogeneous, with evidence that some populations of patients may be...